Direct structural evidence of protein redox regulation obtained by in-cell NMR by Mercatelli, Eleonora et al.
  	

Direct structural evidence of protein redox regulation obtained by in-cell NMR
Eleonora Mercatelli, Letizia Barbieri, Enrico Luchinat, Lucia Banci
PII: S0167-4889(15)00393-6
DOI: doi: 10.1016/j.bbamcr.2015.11.009
Reference: BBAMCR 17720
To appear in: BBA - Molecular Cell Research
Received date: 7 October 2015
Revised date: 4 November 2015
Accepted date: 7 November 2015
Please cite this article as: Eleonora Mercatelli, Letizia Barbieri, Enrico Luchinat, Lucia
Banci, Direct structural evidence of protein redox regulation obtained by in-cell NMR,
BBA - Molecular Cell Research (2015), doi: 10.1016/j.bbamcr.2015.11.009
This is a PDF file of an unedited manuscript that has been accepted for publication.
As a service to our customers we are providing this early version of the manuscript.
The manuscript will undergo copyediting, typesetting, and review of the resulting proof
before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that
apply to the journal pertain.
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
1 
 
 
Direct structural evidence of protein redox regulation obtained by in-cell NMR 
 
Eleonora Mercatelli
a
, Letizia Barbieri
a,b
, Enrico Luchinat
a,c
, Lucia Banci
a,b,1
 
a
Magnetic Resonance Center - CERM, University of Florence, Via Luigi Sacconi 6, 50019 Sesto Fiorentino, Florence, 
Italy. 
b
Department of Chemistry, University of Florence, Via della Lastruccia 3, 50019 Sesto Fiorentino, Florence, Italy. 
c
Department of Biomedical, Clinical and Experimental Sciences, University of Florence, Viale Morgagni 50, 50134 
Florence, Italy. 
 
1
To whom correspondence should be addressed. Telephone: +39 055 457 4273. Email: banci@cerm.unifi.it 
 
 
Abstract 
The redox properties of cellular environments are critical to many functional processes, and are strictly 
controlled in all living organisms. The glutathione-glutathione disulfide (GSH-GSSG) couple is the most 
abundant intracellular redox couple. A GSH redox potential can be calculated for each cellular compartment, 
which reflects the redox properties of that environment. This redox potential is often used to predict the 
redox state of a disulfide-containing protein, based on thermodynamic considerations. However, thiol-
disulfide exchange reactions are often catalyzed by specific partners, and the distribution of the redox states 
of a protein may not correspond to the thermodynamic equilibrium with the GSH pool. Ideally, the protein 
redox state should be measured directly, bypassing the need to extrapolate from the GSH. Here, by in-cell 
NMR, we directly observe the redox state of three human proteins, Cox17, Mia40 and SOD1, in the 
cytoplasm of human and bacterial cells. We compare the observed distributions of redox states with those 
predicted by the GSH redox potential, and our results partially agree with the predictions. Discrepancies 
likely arise from the fact that the redox state of SOD1 is controlled by a specific partner, its copper 
chaperone (CCS), in a pathway which is not linked to the GSH redox potential. In principle, in-cell NMR 
allows determining whether redox proteins are at the equilibrium with GSH, or they are kinetically regulated. 
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Such approach does not need assumptions on the redox potential of the environment, and provides a way to 
characterize each redox-regulating pathway separately. 
Keywords: in-cell NMR; glutathione; redox regulation; nuclear magnetic resonance; disulfide bond 
 
1. Introduction 
Living systems have developed a strict control of the redox cellular environment. In most prokaryotes and all 
eukaryotes, the most abundant redox couple in the cell is the glutathione-glutathione disulfide (GSH-GSSG) 
couple [1,2]. The redox potential of the glutathione pool (E’GSH) in a given cellular compartment, which is 
dependent on the [GSH]
2
/[GSSG] ratio, is therefore a critical parameter to understand the redox properties of 
the environment [1,3]. Consequently, numerous methods have been developed to quantitatively measure the 
absolute and relative concentration of both GSH and GSSG, either by chemical assays on cell extracts [4,5] 
or, more recently, by using GSH-sensitive intracellular fluorescent probes [6–8]. These methods have 
contributed much to understand how the intracellular E’GSH is influenced under physiological and oxidative 
stress conditions, and have shown that some cellular compartments have a less reducing environment with 
respect to the cytoplasm, such as the endoplasmic reticulum (ER) and the mitochondrial inter-membrane 
space (IMS) [3,5,9,10]. In principle, from the E’GSH of the various cellular compartments, the redox state of 
disulfide-containing proteins can be predicted, provided that the midpoint reduction potential (E°’) of each 
protein is known, and such capability has allowed a deeper understanding of the many redox-dependent 
mechanisms of protein maturation, such as the PDI-mediated folding in the ER and the disulfide-relay 
system of the mitochondrial IMS [3,11–13].  
Despite these remarkable examples, sometimes glutathione alone is not sufficient to understand intracellular 
redox processes. In order for the difference (ΔE) between E°’ of a protein and E’GSH to act as a driving force 
for thiol-disulfide redox reactions, allowing the system to move towards the thermodynamic equilibrium 
(given by the Nernst equation), there needs to be a direct reaction between the protein and GSH/GSSG. In 
biological systems, this is usually not the case, as thiol-disulfide reactions would occur on timescales many 
orders of magnitude slower, if they were not catalyzed by specific enzymes [14,15]. Consequently, the actual 
protein redox states cannot always be inferred from E’GSH, as they also depend on the kinetics of the 
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catalyzed reactions. In fact, it has been even suggested that under some circumstances the redox properties of 
an intracellular environment may not depend on E’GSH at all [14,16]. Moreover, the measure of E’GSH itself 
poses some challenges, as the result can vary considerably depending on which method is used [17,18]. 
Ideally, when studying redox-regulated pathways, the redox state of the proteins involved should be 
monitored directly inside the cells, thus bypassing all the assumptions required by the use of E’GSH. For this 
purpose, Nuclear Magnetic Resonance applied to observe proteins in living cells (in-cell NMR) is a 
promising approach. In-cell NMR has been successfully applied to obtain atomic-level information on 
protein structure, dynamics and interactions in both bacterial and eukaryotic cells [19–22]. In particular, in-
cell NMR can be applied to monitor protein maturation pathways involving the formation of one or more 
disulfide bonds [23–26]. NMR is extremely sensitive to changes in protein structure and dynamics, thus it 
easily detects the formation of disulfide bonds as they affect the protein structure and consequently the 
chemical shifts.  
In this work, we report the direct observation of the redox state of three soluble proteins expressed in the 
cytoplasm of both human (HEK293T) and bacterial cells (E. coli BL21 and Origami B strains). By 
integrating the obtained data with previously reported findings, we determined the actual distributions of 
redox states of each protein in different cell types, and we compared them with those calculated from the 
reported E°’ of the protein and cytoplasmic E’GSH of each cell type. Due to the broad range of reported E’GSH 
values, the redox state distributions predicted from the Nernst equation can change considerably. Despite 
this, our data is not always compatible with the range of E’GSH values, suggesting that the observed proteins 
are not at the thermodynamic equilibrium with the environment. We also analyzed how the redox state 
distribution of the observed proteins changes in response of supplemented cofactors or increased levels of 
redox partners. In principle, with a more accurate estimate of E’GSH in our experimental conditions, this 
method could be used to determine how far the steady-state distribution of redox sates of a protein is from 
the equilibrium with the E’GSH of the environment in each cell type. 
 
2. Materials and Methods 
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2.1. Gene cloning 
cDNA encoding full-length human Cox17 (amino acids 1–63, GenBank: NP_005685) was amplified by PCR 
and cloned into the pHLsec [27] vector between EcoRI and XhoI restriction enzyme sites to generate the 
mammalian expression plasmid and into the pET16b plasmid between NdeI and XhoI restriction enzyme 
sites to generate the bacterial expression plasmid. cDNA encoding full-length human Mia40 (amino acids 1–
142, GenBank: NP_001091972.1) was amplified by PCR and cloned into the pET21a between NdeI and 
XhoI restriction enzyme sites to generate the bacterial expression plasmid. All clones were verified by DNA 
sequencing. SOD1 in pET28a, pET21a and pHLsec, and Mia40, Grx1 and Trx1 in pHLsec were cloned as 
previously reported [23–25].  
2.2. Human cell culture and transfection 
HEK293T cells were maintained in DMEM (high glucose, D6546, Sigma) supplemented with L-glutamine, 
antibiotics (penicillin and streptomycin) and 10% FBS (Gibco) in uncoated 75 cm
2
 plastic flasks and 
incubated at 310 K, 5% CO2 in a humidified atmosphere. 
HEK293T cells were transiently transfected with the pHLsec plasmid containing the gene of interest using 
polyethylenimine (PEI), as previously described [24]. Different DNA:PEI ratios were tested for maximizing 
protein expression (PEI was kept constant at 50 µg/flask), and an optimal ratio of 1:1 was used (50 µg/flask 
DNA, 50 µg/flask PEI). For co-expression of Cox17 and Grx1 or Cox17 and Trx1, cells were transfected 
with plasmids containing the constructs in different amounts and ratios. The ratios were chosen in order to 
obtain similar expression levels of Cox17, specifically 1.9:0.1:2 was used for Cox17:Grx1:PEI and 1.5:0.5:2 
for Cox17:Trx1:PEI. To ensure complete activation of Trx1, sodium selenite was supplemented to the cell 
culture media to a final concentration of 100 nM, starting 24 h before transfection. 
During protein expression, commercial DMEM medium was used to prepare unlabeled in-cell NMR 
samples; BioExpress6000 medium (CIL) was used for U-
15
N labelling; for selective [15N]cysteine labelling a 
reconstituted medium was prepared following the DMEM (Sigma) reported composition, in which 
[
15
N]cysteine was added together with all the other unlabelled components. The expression media were 
supplemented with 2% FBS and antibiotics.  
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2.3. Western Blot analysis 
Cox17 expression levels were determined on cell extracts by Western Blot analysis, by using a sample of 
purified Cox17 at increasing dilutions as a reference; Grx1 and Trx1 concentrations in the cell extracts were 
determined as above, by using samples of purified Grx1 and Trx1 as references. Cox17 was stained with a 
rabbit polyclonal anti-Cox17 antibody (Abcam: ab69611, diluted to 0.5 g/ml); Grx1 with a rabbit 
polyclonal anti-glutaredoxin 1 antibody (Abcam: ab45953, 1.0 g/ml); Trx1 with a rabbit polyclonal anti-
thioredoxin/TRX antibody (Abcam: ab26320, 0.4 g/ml). Goat anti-rabbit IgG (whole molecule)-peroxidase 
secondary antibody (Sigma: A0545) was used for detection, diluted at 1:80000. 
2.4. Protein expression and purification 
Pure Cox17 sample was produced following a previously described protocol [28]. Briefly, the pETG-30A 
vector containing the hCox17 gene was transformed in E. coli Origami B (DE3) cells (Novagen). Cells were 
induced with 0.5 mM IPTG for 16 h at 25 °C. Cox17 was purified by affinity chromatography using a nickel 
chelating HisTrap (GE Healthcare) column. After digestion with AcTEV protease (Invitrogen) O/N at 25 °C 
the protein was separated from the affinity tag in a HisTrap column. The sample buffer was then exchanged 
with 50 mM potassium phosphate, 0.5 mM EDTA, pH=7. Grx1 for reference in the WB analysis was 
produced as previously described [25]. Briefly, the pTH34 vector containing the human Grx1 gene was 
transformed in E. coli BL21(DE3) Gold competent cells. Cells were grown at 37 °C in minimal medium until 
O.D. 0.6 and then induced with 0.5 mM IPTG for 16 h at 25 °C. Grx1 was purified by affinity 
chromatography using a nickel chelating HisTrap (GE Healthcare) column. After digestion with AcTEV 
protease (Invitrogen) O/N at 25 °C the protein was separated from the affinity tag in a HisTrap column. The 
sample buffer was then exchanged with 50 mM potassium phosphate, 0.5 mM EDTA, pH=7. Pure Trx1 for 
WB analysis was prepared from HEK293T cells overexpressing Trx1 as previously described [25]. Cells 
were lysed in 20 mM potassium phosphate buffer (pH 7) and the cleared extract was incubated at 70°C for 4 
min. After centrifugation (30 min at 16000 g), Trx1 was purified by anionic exchange chromatography using 
a HiTrap™ DEAE FF (Amersham Biosciences) column applying a linear gradient of potassium phosphate 
buffer (10 to 100 mM, pH 7). 
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2.5. In-cell NMR sample preparation (human cells) 
HEK293T cells for in-cell NMR samples were collected as previously reported [24]. Briefly, cells from a 75 
cm
2
 flask were detached by trypsin treatment and suspended in one cell pellet volume of DMEM medium 
supplemented with 90 mM glucose, 70 mM HEPES buffer and 20% D2O. The cell suspension was 
transferred to a 3 mm Shigemi tube; cells were spun down at the bottom of the tube. Cell viability before and 
after NMR experiments remained above 90%, as determined by trypan blue staining. Cleared cell lysates 
were prepared as follows: cells were suspended in one pellet volume of PBS buffer supplemented with 0.5 
mM EDTA and 4-(2-aminoethyl)-benzenesulfonyl fluoride hydrochloride (AEBSF, Sigma) and lysed by 
freeze-thaw cycles with liquid N2 and warm water. The cell lysate was centrifuged (60 min at 16000g, 4°C) 
and the cleared supernatant was recovered for NMR analysis in a 3 mm standard tube. 
2.6. In-cell NMR sample preparation (bacterial cells) 
U-
15
N Samples for in-cell NMR in E. Coli cells were prepared as follows: a cell culture of BL21 (DE3) Gold 
(Agilent Technologies) or Origami B (DE3) (Novagen) transformed with the plasmid containing the gene of 
interest was grown overnight at 30°C in 35 mL of LB medium. After gentle centrifugation (3000 g) for 20 
minutes, the cells were re-suspended in 50 mL of M9 minimal medium [M9 buffer (7 g/L K2HPO4, 3 g/L 
KH2PO4, 0.5 g/L NaCl, pH 7.4), 2 mM MgSO4, 0.1 mM CaCl2, 1 mg/L biotin, 1 mg/L thiamine, antibiotic] 
containing 1 g/L (
15
NH4)2SO4 and 3 g/L of unlabelled glucose to obtain an OD600 of ~1.6. After 10 min 
recovery time, overexpression was induced with 0.5 mM IPTG, and carried out at 30°C for 4 h. The cells 
were washed once with 50 mL of M9 buffer in order to remove nutrients, metal ions and any excreted by-
product, and they were harvested through gentle centrifugation. The pellet was then re-suspended in M9 
buffer until 500 µL of a ~50% v./v. cell slurry were obtained. 50 µL of D2O were added, and the final 
volume was put in a 5 mm NMR tube. The cleared cell lysates for NMR experiments were prepared as 
follows: the cell pellet was re-suspended in an equal volume of M9 buffer and lysed by ultrasonication. The 
cell lysate was centrifuged (40 minutes at 18000 g, 4°C), the supernatant was collected and its volume was 
brought to 500 µL with M9 buffer; 50 µL of D2O were added. The sampled was placed into a standard 5 mm 
tube for NMR analysis. 
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2.7. In-cell NMR experiments 
NMR experiments on human cells and lysates were acquired at a 950 MHz Bruker Avance III spectrometer 
equipped with a CP TCI CryoProbe. NMR experiments on bacterial cells and lysates were acquired at a 900 
MHz Bruker Avance spectrometer equipped with a TCI Cryoprobe. 1D 
1
H and 2D 
1
H-
15
N SOFAST HMQC 
[29] spectra were acquired at 307 K. The total acquisition time for each cell sample was ~1 h. The 
supernatant of each cell sample was checked in the same experimental conditions to exclude the presence of 
any signal arising from protein leaked out of the cells. The same NMR spectra were also acquired on the cell 
lysates. The NMR spectra were processed with Bruker Topspin software. The 2D NMR spectra acquired on 
U-
15
N labelled human cells and lysates were further processed by subtracting a spectrum of untransfected 
cells/cell lysate acquired in the same experimental conditions and identically processed, to eliminate the 
signals arising from partial 
15
N labelling of other cellular components. 
2.8. Analysis of the redox state distribution 
The ratio of oxidized vs. total protein was calculated as follows: for Cox17, the ratio was obtained by 
integrating crosspeaks in the 2D NMR spectra corresponding to the oxidized and the reduced species (2D 
NMR spectra of [
15
N]cysteine-labelled cells were used for human cells, of U-
15
N labelled lysates for 
bacteria); for Mia40 in human cells, the values previously reported were used [25]; for Mia40 in bacteria, the 
2D NMR spectra of the lysates were used; for SOD1 in human cells, the ratio was obtained by integrating 
crosspeaks in the 2D in-cell NMR spectra corresponding to the oxidized and the reduced species (from a U-
15
N labelled sample for E,Zn-SOD1; from a [
15
N]cysteine-labelled sample for Cu,Zn-SOD1); for SOD1 in 
bacteria, 2D NMR spectra of U-
15
N labelled cells were used. The error bars were obtained by taking the 
standard deviation of the spectral noise as the error of the integrals, followed by error propagation.  
2.9. Redox species plots 
The redox species curves for each protein as a function of the GSH redox potential were calculated from the 
Nernst equation applied to the  reaction between the oxidized protein and 2 GSH molecules: 
                     1 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
8 
 
where Pox and Pred indicate the protein in the oxidized and reduced state, respectively. The corresponding 
Nernst equation at the equilibrium is: 
              
  
  
  
            
           
  2 
where E°’P is the protein midpoint potential at pH = 7; E°’GSH is the reduction potential of GSH at pH = 7; R 
= 8.314 J K
-1
 mol
-1
; T = 310 K; z = 2; F = 96485 C mol
-1
. The GSH reduction potential (E’GSH) in each 
cellular environment is given by:  
             
  
  
  
      
      
   3 
Combining eq. 3 with eq. 2 gives: 
             
  
  
  
      
     
   4 
Which is rearranged to give the fraction of oxidized protein (ox. fraction) as a function of E’GSH: 
            
     
            
 
 
   
 
  
  
            
   5 
The oxidized fraction vs. E’GSH plots were obtained using the reported midpoint potentials for each protein 
(corrected for pH = 7.0): E°’Cox17 = −305 mV[30]; E°’Mia40 ≤ E°’Cox17 [31]; E°’E,Zn-SOD1 = −320 mV  [32]; 
E°’Cu,Zn-SOD1 = −305 mV [32,33]. In the case of Cox17 and Mia40 two disulfide bonds are formed, requiring 
the oxidation of four GSH molecules. However, the redox curve of Cox17 had been previously determined 
experimentally in vitro, and had been fitted with parameters compatible with the oxidation of two GSH 
molecules (i.e. the formation of one disulfide bond, see eq. 1) [30]. Therefore, eq. 5 was also used to 
calculate the redox curves of Cox17 and Mia40. 
 
 
3. Results  
3.1. Mitochondrial CHCH proteins 
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We have analyzed the folding and redox state of two small proteins of the mitochondrial IMS, human Cox17 
and Mia40, in the cytoplasm of human and bacterial cells [28,31]. Like most mitochondrial proteins, Cox17 
and Mia40 are synthesized in the cytoplasm, and have to translocate to the mitochondria [13,34]. Both 
proteins are constituted by a coiled-coil helix coiled-coil helix (CHCH) domain, consisting of two alpha 
helices stabilized through two structural disulfide bonds [35]. In order to reach the IMS, these small CHCH 
proteins can only cross the outer mitochondrial membrane in an unfolded state, therefore with the four 
cysteines of the CHCH motif reduced. 
15
N-labelled Cox17 and Mia40 were overexpressed in the cytoplasm 
of human cells (E’GSH ranging from –300 mV to  –320 mV [36–39]), and the backbone amide signals of the 
folded CHCH domain were detected for both proteins (Fig. 1A,B), with their chemical shifts matching those 
of the in vitro NMR spectra of the folded, oxidized proteins [28,31]. This observation is further confirmed by 
the in-cell NMR spectra of [
15
N]cysteine-labelled proteins (Fig. 1C,D). The ratio of folded Cox17 over total 
Cox17 was determined from the intensities of cysteine crosspeaks corresponding to the oxidized and reduced 
protein (Fig. 1D-F), while the ratio of folded Mia40 over total Mia40 was determined from the intensities of 
a set of crosspeaks in the in-cell NMR spectra of the 
15
N-labelled protein (Fig. 1G-I). For Mia40, this method 
yielded results consistent with previous measurements [25]. This analysis revealed that in the human 
cytoplasm ~70% of Cox17 and ~75% of Mia40 are folded and therefore oxidized (Fig. 2A,B), and 
consequently unable to enter mitochondria. The values obtained were somewhat higher that those predicted 
from the Nernst equation (ranging between 25% and 60% oxidized over total protein) using the reported 
E’GSH values. As we had previously shown [25], the folding state of Mia40 in the human cytoplasm is 
dependent on the levels of the cytoplasmic proteins thioredoxin 1 (Trx1) and glutaredoxin 1 (Grx1): when 
Grx1 or Trx1 were co-expressed with Mia40, the latter shifted towards the unfolded, reduced state as a 
function of Grx1/Trx1 levels (Fig. 2B). A similar, albeit moderate effect on the folding state of Cox17 was 
observed when Grx1 was co-expressed, while co-expression of Trx1 had a smaller effect (Fig. 1E,F, Fig. 2A 
and Fig. S1).  
When Cox17 and Mia40 were expressed in E. coli BL21 cells (E’GSH = –259 / –261 mV [40,41]) both 
proteins were mostly unfolded and in the reduced state, and no folded protein was detected in either intact 
cells or lysates despite the apparently less reducing environment (Fig. 2A,B and Fig. S2). Only when the 
Origami B strain of E. coli was used, which lacks the genes encoding glutathione reductase and thioredoxin 
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reductase, and is even less reducing (E’GSH = –235 mV [41]), the folded conformation was observed again: 
~45% of Cox17 was folded, and Mia40 was completely folded (estimated from the cell lysate due to severe 
signal broadening of the folded domain of both proteins in bacterial cells) (Fig. 2A,B and Fig. S3).  
 
3.2. Superoxide dismutase 1 and its copper chaperone 
Unlike Cox17 and Mia40, which need to be reduced in the cytoplasm in order to reach their functional 
compartment, the cytoplasmic enzyme superoxide dismutase 1 (SOD1) in its active form harbours an 
intramolecular disulfide bond. We have previously characterized the SOD1 maturation process both in 
bacterial and human cells [23,24,26]. SOD1 sequentially binds one zinc ion, dimerizes, and binds one copper 
ion per subunit with simultaneous formation of the disulfide bond. The copper binding step requires the 
interaction with a specific copper chaperone for SOD1 (CCS). CCS also catalyzes the formation of the SOD1 
intramolecular disulfide bond through an intermolecular thiol-disulfide exchange reaction with its C-terminal 
unfolded domain [32,42]. When SOD1 is expressed in human cells it readily binds zinc and dimerizes, and 
the zinc-bound form is observed by in-cell NMR (E,Zn-SOD1, Fig. 3A,B). In these conditions ~85% of 
E,Zn-SOD1 is found in the reduced state, as the endogenous CCS is apparently not sufficient to allow copper 
binding and disulfide bond formation (Fig. 2C). If CCS is co-expressed with SOD1 at similar levels, 
disulfide formation is partial in defect of copper, but almost reaches completion if excess copper is 
supplemented (~80% oxidized SOD1), and the mature protein Cu,Zn-SOD1 is formed (Fig. 2C and 3C,D).  
Zinc binding and dimerization of SOD1 are known to occur spontaneously in bacterial cells, and Cu,Zn-
SOD1 is formed when bacteria are treated with excess copper after protein expression, without the need of 
co-expressed CCS [23,24]. In E. coli BL21 cells E,Zn-SOD1 was mostly observed in the reduced state, 
whereas Cu,Zn-SOD1 was partially oxidized (~60%, Fig. 2C and Fig. S4A,B). In E. coli Origami B cells 
E,Zn-SOD1 had already reached the oxidized state (~85%), and after copper supplementation fully oxidized 
Cu,Zn-SOD1 was observed (Fig. 2C and Fig. S4C,D). 
 
4. Discussion 
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If a disulfide-containing protein is assumed to be at the equilibrium with the environment, the distribution of 
its redox states can be calculated from the difference between E°’ of the protein and E’GSH measured in the 
cellular compartment of interest, using the Nernst equation. When considering some uncertainty in the actual 
E’GSH of the cytoplasm (as shown from the previously reported values), the redox state distribution of each 
observed protein can be expected to fall within a certain range (Fig. 2). In the case of Cox17 and Mia40 
expressed in human cells, our data show that the redox states observed by in-cell NMR fall slightly out of the 
predicted range, towards the oxidized state (Fig. 2A,B). Interestingly, when the levels of redox-regulating 
proteins Grx1/Trx1 are increased, our data agree with the E’GSH values previously reported, indicating that 
those proteins contribute to establish the thermodynamic equilibrium between Cox17/Mia40 and the GSH 
pool. Unlike for Cox17 and Mia40, the data obtained on SOD1 in human cells are not in agreement with the 
predicted redox state distributions: E,Zn-SOD1 is mostly reduced while Cu,Zn-SOD1 is mostly oxidized, 
while in both metallation states SOD1 is expected to populate both states (Fig. 2C). This discrepancy 
suggests that SOD1 never reaches the thermodynamic equilibrium with the GSH pool, and its redox state is 
determined by different factors, e.g. CCS. Indeed the interaction with CCS, which affected dramatically the 
redox state of SOD1, is known to catalyze the formation of SOD1 disulfide bond together with copper 
transfer [43], moving the final distribution of SOD1 redox states further away from the equilibrium with the 
GSH pool. These results suggest that the disulfide exchange between SOD1 and CCS is uncoupled from the 
glutathione pool, and that the redox pathway of CCS is not driven by the glutathione redox potential. On the 
contrary, the Grx1 pathway is expected to be dependent on the glutathione redox potential, as glutaredoxins 
catalyze thiol-disulfide exchange reactions between protein thiols and glutathione [44]. 
The data obtained in E. coli has a larger discrepancy from the predicted distribution of redox states (Fig. 2). 
Indeed, all three proteins are almost completely in the reduced state in E. coli BL21 cells, despite E’GSH being 
less reducing compared to that of the mammalian cell cytoplasm. SOD1 in copper-treated BL21 cells is the 
only exception, as it is partially oxidized upon copper treatment. Only when the proteins are expressed in the 
Origami B strain, which is purposely designed to facilitate the folding of disulfide-containing proteins, all 
three proteins are observed in the oxidized state (either partially in the case Cox17, or completely in the case 
of Mia40 and SOD1). Given these discrepancies, one may speculate that in bacterial cells the distribution of 
oxidation states of our proteins does not reach the equilibrium with the GSH pool, and is mainly controlled 
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by the thioredoxin system (which is non-functional in the Origami B strain). Alternatively, our data could be 
compatible with a lower E’GSH of E. coli cells (both BL21 and Origami B) than the reported values.  
Lastly, discrepancies may also be introduced by macromolecular crowding, a property of the intracellular 
environment, which has been recently shown to affect the stability of protein folding [45–47]. If the change 
in redox state has a large effect on the folding state of a protein, the reduction potential measured in vitro 
may differ from the actual reduction potential in-cell. That would be especially true for Cox17 and Mia40, as 
the CHCH fold is strictly dependent on the disulfide bond formation, while the structure of SOD1 is not as 
much affected. While this effect may explain some discrepancies between the expected protein redox states 
and those actually observed by in-cell NMR, it does not justify the significant changes that occur in the same 
cellular environment when a redox partner is co-expressed at similar levels. Therefore, the observed changes 
are the result of specific redox-regulating processes. 
 
5. Conclusions 
The link between the intracellular glutathione and the redox state of the cell is an established property of 
living organisms. However, analysis at the molecular level reveals that the oxidation state of disulfide-
containing proteins cannot be always predicted from the glutathione redox potential of the cellular 
compartment. By in-cell NMR analysis, we observed the redox state of three human proteins in the 
cytoplasm of human and bacterial cells. By obtaining direct information on the conformational properties of 
each protein in different redox states, we could directly obtain the distribution of redox states, which was 
then compared to the one predicted by assuming the thermodynamic equilibrium with GSH. In human cells, 
co-expression of redox-regulating protein partners altered the distribution of redox states. In bacterial cells 
(BL21) the proteins were mostly reduced, despite the less reducing cellular environment, while in the 
absence of the disulfide reduction pathways (in Origami B cells) the oxidized state of each protein was 
observed. Our results show that in-cell NMR is a suitable method to directly observe the redox state of a 
soluble disulfide-containing protein, and suggest that the oxidation state of some proteins is controlled by a 
specific pathway, which may not be linked to the GSH pool. Understanding such specific redox pathways 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
13 
 
would require focussing on the interactions between the various partners (e.g. SOD1 and CCS) irrespective 
of the GSH pool, similarly to how kinase signalling cascades are studied. 
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Figure Legends 
 
Fig. 1. In-cell NMR spectra of human cells expressing Cox17 and Mia40. (A-C) 
1
H-
15
N SOFAST-HMQC 
spectra of human cells expressing (A) [U-
15
N]-labelled Cox17, (B) [U-
15
N]-labelled Mia40, (C) 
[
15
N]cysteine-labelled Mia40. (D-F) 
1
H-
15
N SOFAST-HMQC spectra of human cells expressing 
[
15
N]cysteine-labelled Cox17 either alone (D) or in presence of increased levels of Grx1 (E) and Trx1 (F). 
(G-I) Selected region of 
1
H-
15
N SOFAST-HMQC spectra of human cells expressing [U-
15
N]-labelled Mia40 
either alone (G) or in presence of increased levels of Grx1 (H) and Trx1 (I). In (C-F), the amide crosspeaks 
corresponding to the cysteine residues in the oxidized, folded conformation are indicated. For Cox17, the 
crosspeak corresponding to a cysteine of the reduced conformation [C(red)] is indicated. In (G-I), the amide 
crosspeaks used to determine the redox state distribution are indicated.  
 
Fig. 2. Protein redox state distributions measured by NMR in different cellular environments. Fraction of 
oxidized Cox17 (A), Mia40 (B) and SOD1 (C), experimentally measured through in-cell NMR in human 
HEK293T, E. coli BL21 and E. coli Origami B cells, plotted against the redox potential of the cytoplasmic 
glutathione pool reported for each cell type (E’GSH, range shown as grey area, single values as dot-dashed 
lines). The oxidized fractions of Cox17 and Mia40 alone are shown as black squares, in presence of 
overexpressed Grx1 and Trx1 as black circles and triangles, respectively. E,Zn-SOD1 fractions are shown as 
red squares; Cu,Zn-SOD1 fractions as blue squares. Error bars are calculated from standard errors. The 
curves represent the predicted fraction of oxidized protein calculated from the Nernst equation for Cox17 
(black), Mia40 (black), E,Zn-SOD1 (red) and Cu,Zn-SOD1 (blue). 
 
Fig. 3. In-cell NMR spectra of human cells expressing SOD1. (A) 
1
H-
15
N SOFAST-HMQC spectrum of 
human cells expressing [U-
15
N]-labelled SOD1 in presence of excess zinc, corresponding to the zinc-bound 
protein (E,Zn-SOD1); (B) detail of the NMR spectrum (A) with lower contour levels showing the crosspeaks 
arising from the Asn53 HNδ1, HNδ2 of E,Zn-SOD1SS (ox) and E,Zn-SOD1SH (red); (C) 1H-15N SOFAST-
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HMQC spectrum of human cells expressing [
15
N]cysteine-labelled SOD1 in presence of excess zinc and 
copper, and increased levels of CCS, in which Cu,Zn-SOD1 is observed; (D) detail of the NMR spectrum (E) 
with lower contour levels showing the crosspeaks arising from Cys146 of Cu,Zn-SOD1
SS
 (ox) and Cu,Zn-
SOD1
SH
 (red). 
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Highlights 
 Protein redox state distributions can be measured directly in living cells by NMR. 
 Some proteins do not reach the equilibrium with the intracellular glutathione pool. 
 Non-equilibrium distributions indicate kinetic regulation by specific partners. 
